ストックスクリーナーアプリを入手
1.83
3.39%
0.06
アフターアワーズ：
1.67
-0.16
-8.74%
前日終値:
$1.77
開ける：
$1.68
24時間の取引高:
6,083
Relative Volume:
0.15
時価総額：
$9.97M
収益：
-
当期純損益:
$-2.25M
株価収益率:
-3.8445
EPS:
-0.476
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.55%
1か月 パフォーマンス:
-6.39%
6か月 パフォーマンス:
-34.64%
1年 パフォーマンス:
+77.67%
1日の値動き範囲:
$1.6743
$1.83
1週間の範囲:
$1.6743
$1.85
52週間の値動き範囲:
$0.76
$4.9897
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
XTLB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| XTLB | 1.83 | 9.97M | 0 | -2.25M | 0 | -0.476 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-05-08 | 開始されました | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr (XTLB) 最新ニュース
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion - TipRanks
XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com
XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks
A stock that deserves closer examination: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) – US Post News - US Post News
XTL Biopharmaceuticals Announces Upcoming Shareholder MeetingTipRanks.com - TipRanks
XTL Biopharmaceuticals acquires AI firm Social Proxy By Investing.com - Investing.com
XTL Biopharmaceuticals acquires AI firm Social Proxy - Investing.com India
XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.TipRanks.com - TipRanks
XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewswire Inc.
Market Recap: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB)'s Positive Momentum, Closing at 2.62 – DWinneX - The Dwinnex
XTL Biopharmaceuticals Expands Portfolio Amidst Profitable QuarterTipRanks.com - TipRanks
XTL Biopharmaceuticals Regains Nasdaq ComplianceTipRanks.com - TipRanks
XTL Biopharmaceuticals Convenes Extraordinary General MeetingTipRanks.com - TipRanks
Enhance Your Investment Strategy with Altman Z-Score Screener By Investing.com - Investing.com India
XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidanc - Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data - Benzinga
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial - Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
List of US Companies Releasing Earnings (EPS) Today - FX Leaders
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 T - Benzinga
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - Yahoo Finance
15 Biggest Mid-Day Gainers For ThursdayCuris (NASDAQ:CRIS), Federal Agricultural (NYSE:AGM), Canadian - Benzinga
Mid-Afternoon Market Update: Monotype Drops On Earnings Miss; LMI Aerospace Shares Spike HigherDeere ( - Benzinga
Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter - Benzinga
Morning Market LosersCentury Aluminum (NASDAQ:CENX) - Benzinga
X T L Biopharmaceuticals Ltd Adr (XTLB) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):